Literature DB >> 17903153

Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.

David Farhi1, Nicolas Dupin, André Palangié, Agnés Carlotti, Marie-Françoise Avril.   

Abstract

BACKGROUND: Reported rates of incomplete excision of basal cell carcinoma (BCC) range from 4% to 16.6%.
OBJECTIVE: The objective was to assess, in clinical practice, the rate and the factors associated with pathologically reported incomplete excision of BCC.
METHODS: In this retrospective monocentric study, data from all surgically excised BCCs during the year 2004 were computerized. Age, sex, number of BCC excised during the same surgical session, BCC location, pathologic types, and involvement of surgical margins were analyzed.
RESULTS: Mean age of the 284 patients was 67.4+/-14.9 (SD) years (range, 27-96 years). A total of 52.7% of the 362 BCCs were located on the face (including nose, 10%; eyelids, 4.2%; lips, 2%; and ears, 2.2%). Incomplete excisions occurred in 10.3% of the cases including 8.6% of positive lateral margins and 2.5% of positive deep margins. In the multivariate analysis, incomplete excision was independently associated with location on the nasal ala (p<.02), other parts of the nose (p=.02), and inner canthus (p=.01) and with infiltrative (p<.0001) and multifocal (p<.0001) types.
CONCLUSION: Pathologically reported incomplete excision rate was comparable to that of other studies and was significantly associated with the location on the face, particularly on the nose and inner canthus, and with infiltrative and multifocal histologic types.

Entities:  

Mesh:

Year:  2007        PMID: 17903153     DOI: 10.1111/j.1524-4725.2007.33255.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  25 in total

1.  Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.

Authors:  Zornitsa I Zlatarova; Ekaterina B Softova; Klara G Dokova; Elisabeth M Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

2.  Total Margin-Controlled Excision is Superior to Standard Excision for Keratinocyte Carcinoma on the Nose: A Veterans Affairs Nested Cohort Study.

Authors:  Paul R Massey; Sameer Gupta; Brooke E Rothstein; Nellie Konnikov; Meera Mahalingam; Emily S Ruiz; Chrysalyne D Schmults; Abigail Waldman
Journal:  Ann Surg Oncol       Date:  2021-03-19       Impact factor: 5.344

3.  Staged-surgery with permanent pathology for the management of high-risk nonmelanoma skin cancer of the nose.

Authors:  Görkem Eskiizmir; Gülsüm Gençoğlan; Peyker Temiz; Zafer Hirçin; Aylin Ermertcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-08       Impact factor: 2.503

4.  Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.

Authors:  Ki Woong Ro; Soo Hong Seo; Sang Wook Son; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

5.  Infiltrating basal cell carcinoma: a stellate peri-tumor dermatoscopy pattern as a clue to diagnosis.

Authors:  John H Pyne; Paul Fishburn; Anthony Dicker; Michael David
Journal:  Dermatol Pract Concept       Date:  2015-04-30

Review 6.  Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

7.  Incomplete removal of basal cell carcinoma: what is the value of further surgery?

Authors:  Shiralee S Patel; Sandeep H Cliff; Peter Ward Booth
Journal:  Oral Maxillofac Surg       Date:  2012-08-07

8.  Clinicopathological Factors Associated with Incomplete Excision of High-risk Basal Cell Carcinoma.

Authors:  Hannah Ceder; Annie Ekström; Lajla Hadzic; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-07-13       Impact factor: 3.875

9.  Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology.

Authors:  Francisco Bobadilla; Ximena Wortsman; Carla Muñoz; Laura Segovia; Miguel Espinoza; Gregor B E Jemec
Journal:  Cancer Imaging       Date:  2008-09-22       Impact factor: 3.909

10.  Mohs Micrographic Surgery for Primary Versus Recurrent or Incompletely Excised Facial High-risk Basal Cell Carcinomas.

Authors:  Hannah Ceder; Malin Grönberg; John Paoli
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.